Statement of Changes in Beneficial Ownership (4)
August 17 2018 - 7:51PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Estate of Edwin H. Wegman
|
2. Issuer Name
and
Ticker or Trading Symbol
BIOSPECIFICS TECHNOLOGIES CORP
[
BSTC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O TOBY WEGMAN, 4092 BOCAIRE BLVD.
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/18/2016
|
(Street)
BOCA RATON, FL 33487
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.001 par value
|
5/18/2016
|
|
S
|
|
50
|
D
|
$33.80
|
1005128
|
D
|
|
Common Stock, $0.001 par value
|
5/18/2016
|
|
S
|
|
150
|
D
|
$33.14
|
1004978
|
D
|
|
Common Stock, $0.001 par value
|
5/18/2016
|
|
S
|
|
50
|
D
|
$34.11
|
1004928
|
D
|
|
Common Stock, $0.001 par value
|
5/18/2016
|
|
S
|
|
24750
|
D
|
$33.00
|
980178
|
D
|
|
Common Stock, $0.001 par value
|
8/29/2016
|
|
S
|
|
1607
|
D
|
$37.6107
(1)
|
978571
|
D
|
|
Common Stock, $0.001 par value
|
8/30/2016
|
|
S
|
|
2692
|
D
|
$37.5027
(2)
|
975879
|
D
|
|
Common Stock, $0.001 par value
|
9/1/2016
|
|
S
|
|
7935
|
D
|
$37.533
(3)
|
967944
|
D
|
|
Common Stock, $0.001 par value
|
9/2/2016
|
|
S
|
|
1266
|
D
|
$37.5
|
966678
|
D
|
|
Common Stock, $0.001 par value
|
9/13/2016
|
|
S
|
|
3605
|
D
|
$37.545
(4)
|
963073
|
D
|
|
Common Stock, $0.001 par value
|
9/15/2016
|
|
S
|
|
3100
|
D
|
$41.21
(5)
|
959973
|
D
|
|
Common Stock, $0.001 par value
|
11/29/2016
|
|
S
|
|
10000
|
D
|
$48.0832
(6)
|
949973
|
D
|
|
Common Stock, $0.001 par value
|
8/17/2018
|
|
S
|
|
2500
|
D
|
$51.8912
(7)
|
947473
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
The selling price of $37.6107 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.51 to $37.625. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(2)
|
The selling price of $37.5027 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.5005 to $37.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(3)
|
The selling price of $37.533 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.50 to $37.55. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(4)
|
The selling price of $37.545 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.50 to $37.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(5)
|
The selling price of $41.21 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $41.1501 to $41.30. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(6)
|
The selling price of $48.0832 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.00 to $48.2501. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
(7)
|
The selling price of $51.8912 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.8641 to $52.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Estate of Edwin H. Wegman
C/O TOBY WEGMAN
4092 BOCAIRE BLVD.
BOCA RATON, FL 33487
|
|
X
|
|
|
Signatures
|
/s/ Toby Wegman by Carl A. Valenstein, attorney in fact
|
|
8/17/2018
|
**
Signature of Reporting Person
|
Date
|
/s/ Thomas L. Wegman by Carl A. Valenstein, attorney in fact as Co-Executors Of The Estate Of Edwin H. Wegman
|
|
8/17/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Sep 2023 to Sep 2024